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An easing and efficiently synthesized biologically and pharmacologically active quinolinyl- tethered pyrazoline 
molecules in the presence of chalcones, have been obtained from condensation of corresponding aldehydes and ketones, 
through concomitant utilization of aryl hydrazide as useful starting substrates underwent Michael-addition followed by 
domino cyclization. The final products have been obtained in excellent yields, and they have been well characterized using 
FTIR, 1H, 13C NMR and mass spectral analyses. Moreover, all the newly synthesized molecules have been examined for the 
antimicrobial and anticancer activities by MTT assay as well as molecular docking studies. 
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Synthesis of heterocyclic compounds particularly the 
nitrogen containing motifs plays a significant role in 
the establishment of diverse biological active 
molecules
1
. Chalcone, acts as a simple chemical 
scavenger of numerous naturally occurring 
compounds which are broadly existing in vegetables, 
fruits, teas, and other plants. In addition, these 
quinoline- appended pyrazoline motifs have been 
utilized for the synthesis of wide variety of 
compounds with useful pharmacological activities 
viz., antiviral, anti-inflammatory, anti HIV, 
antimicrobial, anticancer, antitumor, anticonvulsant, 
antimalarial, anti-amoebic and antioxidant activities
2-
6
. These molecules can be embedded into nanocarriers 
for targeted delivery and can be used as a nano drug 
delivery system
7,8
. Some of the representative 
compounds are used as fluorescent dyeing agent, 





Many of the synthetic strategies 
have been employed for an efficient construction of 
different quinoline tethered pyrazoline molecular 
architectures. Fascinatingly, the Michael-addition 
mediated domino cyclization strategy for the 
synthesis of our final (quinoline containing pyrazoline 
based) products is one of the facile and expedient 
routes. However, the domino synthesis is an 
imperative strategy in which a process of involving 
two or more bond forming reactions usually C-C 
bonds under the identical conditions without addition 
of reagents and catalysts for subsequent results is thus 
functionality formed in the previous process. 
Adopting this protocol in our present study, we have 
established the synthesis of quinoline containing 
pyrazoline scaffolds from chalcone through aldol 




Chemicals were obtained for the construction of 
products from Sigma-Aldrich Chemicals (USA) and 
Merck (India). 
Physical-chemical characteristics 
The melting points were obtained using capillary 
method. The FT-IR spectral data was obtained in 







C NMR spectral data 
evidenced at the range of 500 MHz, and 125 MHz 
correspondingly in deutriated chloroform at BRUKER 
AV ΙΙΙ spectrometer in TMS (internal standard). The 
chromatographic (TLC) analysis was conducted on 
coated silica plates through spot identifications with 
an aid of UV lamp and iodine chamber. 
Synthesis of (E)-3-(2-Chloro-8-methylquinolin-3-yl)- 
1-phenylprop-2-en-1-one compounds (3)
A stirred solution of substituted 4-methyl
acetophenone (2) (0.01 mmol), with 8-methyl-2- 




chloroquinoline-aldehyde (1) (0.01 mmol) in ethanol 
solvent (20 mL) was kept in a RB flask and then kept 
in an ice bath. After, NaOH solution of 10 mL (40%) 
was added in drops and constantly stirred for half an 
hour. The mixture was continued for 2–3 h at room 
temperature, further it was kept back in a refrigerator 
until it thickened. Then crude mass was poured in to 
cold water (40 mL). Furthermore, the resulting 
products were then filtered and washed thoroughly 
with cold water. Eventually, we had obtained the  





dihydro-1H-pyrazol-1-yl) (pyridin-4-yl) methanone 
compounds (5a) 
A stirred solution of quinoline comprising 
chalcones 3 (1 mmol) and pyridine-4-carboxylic acid 
hydrazide 4a (1 mmol) in ethanol (15 mL) solvent 
was kept in 100ml RB flask, further the catalytic 
amount of AcOH was added and allowed to reflux at 
4 h. After completion of reaction through successive 
monitoring using TLC analysis, the crude reaction 
mass was poured into ice cold water. The result was 
pale yellowish solid which was filtered and washed 
with hot ethanol
11
. The isolated yield of the pure 





A stirred solution of quinoline comprising 
chalcones 3 (1 mmol) and 3-methoxybenzohydrazide 
4b (1 mmol) in ethanol (10 mL) solvent kept in 100 
mL RB flask, further the catalytic amount of AcOH 
was added and allowed to reflux at 4 h. After 
completion of reaction through successive monitoring 
using TLC analysis, the crude reaction mass was 
poured into ice cold water. The resulted pale 
yellowish solid thus obtained was filtered and washed 
with hot ethanol
11
. The isolated yield of the pure 




A stirred solution of quinoline comprising 
chalcones 3 (1 mmol) and furan-2-carbohydrazide 4c 
(1 mmol) in ethanol (20 mL) solvent were kept in  
100 mL RB flask. Then catalytic amount of AcOH 
was added and allowed to reflux at 4 h. After 
completion of reaction, through successive monitoring 
using TLC analysis, the crude reaction mass was 
poured into ice cold water. The resulted pale 
yellowish solid thus obtained was filtered and washed 
with hot ethanol
9
. The isolated yield of the pure 






): 3065 (Aromatic CH), 2855, 2923 
(Aliphatic CH),1732 (C=O), 1602 (C=C); 
1
H NMR 
(500MHz, CDCl3): δ 8.44-7.32 (Aromatic-H, 10H), 2.76 
(Quinoline methyl-H,3H), 2.45 (Aromatic methyl-H, 
3H) ppm; 
13
C NMR (125MHz, CDCl3) δ 189.44, 
149.37, 147.12, 144.15, 139.28, 136.77, 136.41, 135.09, 
131.67, 129.48, 128.36, 128.86, 128.26, 127.74, 127.44, 




Nature of the compound : Brown colour solid, 
Yield : 89 %, M. P : 124-125 °C, Rf : 0.63  
(H: EtOAc/1:1), FTIR (KBr, cm
-1
) 3056, 3023 
(Aromatic CH), 2973, 2924 (Aliphatic CH), 1646 
(C=O), 1565 (C=C), 1338 (C=N); 
1
H NMR (500MHz, 
CDCl3): δ 8.57 (d, J.=.5Hz, 2H), 7.73 (d, J.=.10Hz, 
2H), 7.54 (d, J.=.10Hz,2H), 7.31 (d, J.=.10Hz, 2H), 
7.18-7.15 (m, 4H), 5.68 (dd, J1,2= 10Hz, 15Hz, 1H), 
3.73 (dd, J1,2=10Hz, 15Hz, 1H), 3.14 (dd, J1,2=15Hz, 
20Hz, 1H), 2.36 (s, 6H) ppm; 
13
C NMR (125MHz, 
CDCl3): δ 164.31 (C=O), 154.87, 149.72, 141.58, 
138.57, 137.76, 136.91,128.07, 127.15, 126.29, 
123.64, 61.03 (Pyr-CH), 41.54 (Pyr-CH2), 15.76 (Me) 
ppm; HRMS(ESI): Anal.Calcd. for (C26H21ClN4O) 




Scheme 1 — Construction of quinoline tethered pyrazoline frameworks 






Nature of the compound : Brown Colour solid, Yield 
: 85 %, M. P : 102-103°C, Rf : 0.52 (H: EtOAc/1:1), 
FTIR (KBr, cm
-1
) 3054, 3026 (Aromatic CH), 2927 
(Aliphatic CH), 1646 (C=O), 1596 (C=C), 1339 (C=N); 
1
H NMR (500MHz, CDCl3): δ 7.72-7.70 (m, 2H), 7.65 
(d, J = 10Hz, 1H), 7.55 (s, 1H), 7.50 (d, J = 10Hz, 1H), 
7.41-7.29 (m, 4H), 7.20 (t, J = 10Hz, 1H), 7.07 (t, J = 
10Hz, 2H), 6.03 (dd, J1,2= 10Hz, 15Hz, 1H), 3.83 (s, 
3H), 3.81 (dd, J1,2= 5Hz, 15Hz, 1H), 3.38 (dd, J1,2= 5Hz, 
15Hz, 1H), 2.48 (s, 6H) ppm; 
13
C NMR (125MHz, 
CDCl3): δ 166.28 (C=O), 159.06, 154.69, 140.10, 
137.49, 135.37, 131.25, 130.56, 128.82, 128.70, 127.56, 
126.80, 122.68, 121.66, 120.59, 119.75, 117.58, 114.93, 
109.34, 60.83 (Pyr-CH), 40.63 (Pyr-CH2), 15.63 (Me) 
ppm; HRMS(ESI): Anal.Calcd. for (C28H24ClN3O2) 




Nature of the compound : Brown Colour solid, Yield 
: 87 %, M. P : 115-116°C, Rf : 0.58 (H: EtOAc/1:1), 
FTIR (KBr, cm
-1
): 3047, 3028 (Aromatic CH), 2924 
(Aliphatic CH), 1649 (C=O), 1596 (C=C), 1339 (C=N); 
1
H NMR (500MHz, CDCl3): δ 7.80-7.77 (m, 2H), 7.68 
(dd, J= 5Hz, 1H), 7.58 (m, 1H), 7.46-7.43 (m, 3H), 7.29 
(dd, J= 10Hz, 1H), 7.18-7.14 (m, 1H), 7.04-7.00 (m, 
1H), 6.55-6.54(m, 1H), 5.96 (dd, J1,2= 5Hz, 15Hz, 1H), 
3.88 (dd, J1,2= 5Hz, 15Hz, 1H), 3.38 (dd, J1,2= 5Hz, 
20Hz, 1H), 2.42 (s, 6H) ppm; 
13
C NMR (125MHz, 
CDCl3):  δ 163.59 (C=O), 155.98, 155.40, 145.58, 
139.86, 131.21, 130.73, 128.94, 126.85, 121.68, 120.53, 
119.71, 119.23, 111.66, 109.41, 61.42 (Pyr-CH), 41.12 
(Pyr-CH2), 15.68 (Me) ppm; HRMS(ESI): Anal.Calcd. 
for (C25H20ClN3O2) (M+1): 429.1244, found: 430.1605. 
 
Microbial activity 
Antibiotic sensitivity was tested against the 
synthesized compounds in the selected Gram- positive 
and negative organisms. The pure pyrazoline products 
were synthesized chemically and its antibacterial 
activity was analyzed by disc diffusion method 
against selected microbes. The selected organisms 
were cultured in nutrient broth and the OD of the each 
organism was checked in their log phase (OD 0.8 to 
0.9), 0.1 mL of each culture was spread on nutrient 
agar plate aseptically (Sterile swap technique). The 
synthesized 50µM concentration of the quinoline 
pyrazoline compounds was sterilized aseptically 
under UV illumination (5 to 10 min) to maintain the 
sterility of the compound. The aseptically prepared 
paper disc was impregnated in to the synthesized 
compounds for 5 to 10 min to attain the maximum 
absorption and each paper disc with compound was 
placed in different region in the selected bacterial 
lawn to assess the antibiotic activity. The prepared 
discs were aseptically placed on bacterial lawn and 






Production of HeLa cell suspension  
A subculture of HeLa cell lines in Dulbecco’s 
Modified Eagle’s Medium (DMEM) was trypsinized 
separately, after discarding the culture medium. To 
the disaggregated cells in the flask 25 mL of DMEM 
with 10% FBS was added. The cells were suspended 
through the medium by gentle passage with the 
pipette and the cells homogenized. 
 
Cells seeding 
   The homogenized cell suspension (1 mL) was added 
to each well of a 24 well culture plate along  
with different concentration of tested sample (0 to  
200 µg/mL) and incubated at 37C in a humidified 
CO2 incubator with 5% CO2. After 48 h incubation 
the cells were observed under an inverted tissue 
culture microscope and 80% confluence of cells 





The assay was carried out using (3- (4, 5-dimethyl 
thiazol-2-yl) -2, 5-diphenyltetrazoliumbromide (MTT), 
in which it is cleaved by mitochondrial succinate 
dehydrogenase and reductase of viable cells, yielded a 
measurable purple product formazan. This formazan 
production is directly proportional to the viable cell 
number and inversely proportional to the degree of 
cytotoxicity. After 48 h incubation the wells were 
added with MTT and left for 3 h in room temperature. 
All wells were removed from the content using 
pipette and 100µl SDS in DMSO were added to 
dissolve the formazan crystals, the absorbance read in 





Theoretical view of the pyrazoline compounds was 
established by using molecular docking studies. The 
three dimensional (3D) structures of the COX-2 (PDB 
ID: 6COX) were obtained from protein data bank. Auto 
Dock 4.2 suited programs which utilizes the Lamarckian 
Genetic Algorithm (LGA) which was used for the 
study
15
. Before performing docking, hydrogen atoms, 
charges were added to this crystal structures as required 




in the Lamarckian Genetic Algorithm. The chemical 
structures were not available in the pubchem database. 
So, we used Chemdraw to draw the compound structure 
and all these ligands were prepared for molecular 
docking studies using Auto Dock Tools (ADT). The grid 
size along the x-, y-, z- axes was set to 126 Å, 126 Å and 
126 Å, the grid spacing was set as 0.475 Å, the grid 
centre was set as 29.117 Å, 29.128 Å, and 0.448 Å for 
COX-2. The auto docking parameters used were as 
follows: GA population size = 150; maximum number 
of energy evaluations = 250000; GA crossover mode = 
two points. The lowest binding energy conformer was 
searched out of 20 different conformers for each docking 
simulation, and the resultant one was used for further 
analysis. The docked conformations were viewed using 
PyMoL
16 
(http://www.pymol.org) software package. 
 
Results and Discussion 
The 8-methyl quinolone derived chalcone 
compound 3 associated FTIR spectrum showed the 
characteristic stretching absorption band of C=C, 
C=O, aromatic CH, aliphatic CH and C-Cl 





H NMR spectrum of 8-methyl 
quinolone chalcone compound 3 showed the aromatic 
methyl quinoline attached methyl proton at 2.45 ppm 
and 2.77 ppm as singlet. The olefinic two protons 
showed peaks at 8.21 ppm and 7.62 as doublet  
with the coupling constant of J = 15 Hz. The aromatic 
(ten) protons showed the corresponding peaks at  
8.44-7.26 ppm as multiplet. Subsequently, the 
13
C 
NMR spectrum of 8-methyl Quinolinechalcone 
compound 3 showed the carbonyl carbon peak at 
189.48 ppm. Along with this the quinolone based 
methyl and aromatic methyl carbon peaks presented at 
21.72 ppm and 17.73 ppm accordingly. 
The 8-methyl quinoline-pyrazoline compound 5a 
of FTIR spectrum showed the aromatic and aliphatic 
stretching band at 3056, 3023, 2973 and 2924 cm
-1
. 










NMR spectrum of 8-methyl Quinoline Pyrazoline 
compound 5a showed aromatic methyl six protons at 
2.36 ppm singlet. The five membered Pyrazoline 
methine and methylene protons is ABX type, so it 
showed in three doublet of doublet at 5.68, 3.73, and 
3.14 ppm and the coupling constant J = 10 Hz, 15 Hz 
and 20 Hz respectively. 
13
C NMR spectrum  of 8-
methyl Quinoline-pyrazoline compound 5a showed 
methine and methylene carbon at 41.54 ppm, 61.03 
ppm, respectively. The aromatic methyl carbon peak 
showed at 15.76ppm. Mass spectrum of the compound 




C NMR spectrum of 
compounds 5b and 5c gives supplementary. The mass 
values of compounds 5b and 5c were found as 469.0482 
and 430.1605 respectively. 
The synthesized compounds pyridine, 2-methoxy and 
2-furoic substituted aresensitive to both G+ and G- 
organisms, those compounds were shown (Fig. 1) in 
various series of zone of inhibition (in mm) on disc 
diffusion method. Hence, we concluded that, these 
synthesized compounds can be used as effective as α-
pinene and pyrrole
17-19
 compounds towards 




The anticancer and docking results were 
summarized in Table 1. It was observed that 
quinoline-pyrazoline derivative of compound 5a 
containing pyridine, which showed the most potent 
inhibitory activity in HeLa cell line. Among them, 
compound 5b and 5c displayed the good activity, 
because furan ring and methoxy group substitutes to 
phenyl ring presented in the 3
rd
 position.  
 
Molecular docking 
Theoretical study of synthetic pyrazoline 
compounds 5a, 5b and 5c with bio macromolecules 
provides insight into the preferred binding location 
and also helps to validate experimental observations. 
In this work Auto Dock-based blind docking was 
performed to investigate the exact binding location for 
all synthetic compounds at the active site of COX-2. 
During the docking process, the lowest binding 
energy conformer was searched out of 20 different 
conformers for each docking simulation and the 
resultant one conformer was used for further analysis. 
 
 
Fig. 1 — Antimicrobial activity profiles of synthesized quinoline-
pyrazoline compounds on selected microorganism. 
 




Molecular docking of quinoline-pyrazoline compounds with 
COX-2 (PDB: 6COX) 
The docking simulation of synthesized compounds 
tightly bound with the active site of the COX-2. The 
docking summary of compounds with COX-2 is listed 
in Table 1. Upon the examination of docking features 
in which the compound 5a had the lowest binding 
energy (-11.78 kcal/mol) and established the two 
hydrogen bonding between the 3
rd
 nitrogen atom of 
pyridine ring with charged negative residue of 
ARG44 (bond distance 2.2 Å), the 6
th
 nitrogen  
atom of quinoline ring had polar residue of ASN39 
(bond distance 3.4 Å). Polar and charged negative 
ASN34, GLN42, CYS41,ASN43, GLN461, GLU46, 
ARG469, GLU465 were the binding site of COX-2 
protein (PDB: 6COX) and LYS468. Furthermore  
the following residues were mainly involved in 
hydrophobic interactions (Fig. 2 and 3). 
 
 
Fig. 3 — Binding interaction of the compound 5a in binding pocket of COX-2. 
 





No. of  
H bonds 
Hydrogen bonds between the atoms of compounds  








5a -11.78 2 ARG 44(2HH1),  
ASN 39(OD1) 
N6, N3 2.2, 3.4 24.62 
5b -11.23 2 GLY 135(O),  
CYS 47(HN) 
N1, O1 2.5, 1.8 49.09 
5c -10.86 4 ASN 34 (1HD2),  
GLY 135(O), 
CYS 47(O, HN) 
N2, O1,  
O7, O7 
2.3, 2.8, 2.4, 2.6 36.50 
CisPlatin      13.60 




Fig. 2 — Binding mode of compound 5a. 
 





In the present study, the quinoline-pyrazoline 
compounds were synthesized along with in vitro and 
in silico studies for examination. The structures 
proposed for all the final compounds were confirmed 
by spectroscopic characterizations. Besides, these 
compounds were tested against microbial pathogens 
and found that they posses potential antimicrobial 
activity. 5a, 5b and 5c were evaluated for anticancer 
properties in HeLa cell line. The compound 5a, 5b and 
5c have also exhibited significant anticancer activity. 
The molecular docking study of the compounds was 
carried out for the better understanding of the drug-
receptor interaction. IC50 values of all the active 
compounds are comparable with standard drug  
Cis-Platin. All the compounds possessed with the 
required binding energy to dock itself with the 
binding pocket of COX-2 ranging from -11.78 to -
10.86 kcal/mol. The anticancer activities of these 
compounds are fully supported by the in silico 
molecular docking study.  
 
Acknowledgement 
One of the authors, S. Muniraj is thankful for  
the financial support by the University Grant 
Commissions (UGC), Hyderabad-500001, under the 
project grants no.F MRP-5615/15(SERO/UGC), Link 
no: 5615, Comcode: TNMD013, January 2015. The 
authors are grateful to The Convener of ICACSEM-
2020 for selecting our work for manuscript 
preparation and publication. The authors also thank 
Sophisticated Analytical Instrumentation Facility 
(SAIF), IIT Madras for analytical support. 
 
References 
1 Suresh K, Sandhya B & Himanshu G, Mini Rev Med Chem,  
9 (2009) 1648. 
2 Karad S C, Purohit V B, Thakor P, Thakkar V R & Raval D K, 
Eur J Med Chem, 112 (2016) 270. 
3 Montoya A, Quiroga J, Abonia R, Nogueras M, Cobo J & 
Insuasty B, Molecules, 19 (2014) 18656. 
4 Mahajan P, Nikam M, Asrondkar A, Bobade A & Gilla C,  
J Heterocycl Chem, 54 (2017) 1415. 
5 Faisal H, Attar S, Sadiq U & Amir A, Eur J Med Chem,  
45 (2010) 4669. 
6 Jiunn-H P, Yu-Ma C, Houn-Lin C & Bo-Cheng W, J Sci and 
Eng, 8 (2005) 175. 
7 Khargonekar P, Sinskey A, Miller C & Ranganathan B, 
Cancer Sci Res Open Access, 4 (2017) 1 
8 Ramprasath R, Praveen R, Ranganathan B, Tan C, Sridhar T M 
& Gimbun J,  Mater Today: Proc, 19 (2019) 1241 
9 Hassane L, Rachid S, Abdelkarim C, Shubhalaxmi S J & 
Subrahmanya B K, Cogent Eng, 5 (2018) 1441585. 
10 Ethiraj K R, Nithya P, Krishnakumar V, Jesil M A &  
Nawaz K F, Res Chem Intermed, 39 (2013) 1833. 
11 Sakthinathan S P, Vanangamudi G & Thirunarayanan G, 
Spectrochim Acta, 95 (2012) 693. 
12 Cruickshank R, Duguid J P, Marion B P & Swain R H A, 
Medical Microbiology: A Guide to the Laboratory  
Diagnosis and Control of Infection. Twelfth ed. Medicinal 
Microbiology, Churchil Livingstone, London, 2 (1975) 196. 
13 Abondanza T S, Oliveira C R, Barbosa C M V, Pereira F E G, 
Cunha R L O R, Caires A C F, Comasseto J V, Queiroz  
M L S, Valadares M C & Bincoletto C, Food Toxicol, 46 
(2008) 2540. 
14 Mosmann T, J Immunol Methods, 65 (1983) 55. 
15 Morris G M, Huey R, Lindstrom W, Sanner M. F,  
Belew R K, Goodsell D S & Olson A J, J Comput Chem, 30 
(2009) 2785. 
16 Shuguang Y, Stephen C H C & Zhenquan H, WIREs Comput 
Mol Sci, 7 (2017) 1298. 
17 Murugan E & Ayyanar S, J Mol Catal A-Chem, 235 (2005) 220. 
18 Murugan E & Gopinath P,Appl Catal A-Gen, 319 (2007)  
72. 
19 Murugan E & Gopinath P, J Mol Catal A-Chem, 294 (2008) 68. 
 
